8-K: Baxter International Appoints Jeffrey A. Craig to Board of Directors
Director Appointment Announcement
Baxter International Inc. has appointed Jeffrey A. Craig, former CEO of Meritor Corporation, to its Board of Directors, effective September 9, 2024.
Summary
- Baxter International Inc. has appointed Jeffrey A. Craig to its Board of Directors, effective September 9, 2024.
- Mr. Craig will also serve as a member of the Audit Committee.
- His appointment increases the total number of directors on the board to 12.
- Mr. Craig previously served as CEO and President of Meritor, Inc. from 2015 to 2021.
- He also held various other leadership positions at Meritor, including CFO and COO.
- Prior to Meritor, Mr. Craig was President and CEO of GMAC's Commercial Finance organization.
- Mr. Craig will receive compensation as per the company's Non-Employee Director Compensation Plan.
- He will also be granted equity awards for his service from September 8, 2024, to the 2025 annual meeting of stockholders.
Sentiment
Score: 7
Explanation: The document reflects a positive development with the appointment of an experienced director, but it is a routine corporate governance event and not a major catalyst for significant sentiment change.
Positives
- The appointment of Jeffrey A. Craig brings significant financial and operational expertise to Baxter's board.
- Mr. Craig's experience as a former CEO, CFO, and COO of a public company is a valuable asset.
- His background in auditing and finance strengthens the Audit Committee.
- The addition of Mr. Craig increases the board's diversity of experience.
Management Comments
- Jos (Joe) E. Almeida, chair, president and CEO, stated that Mr. Craig's broad-based business leadership and operational expertise will be a tremendous complement to the current board membership.
Industry Context
The appointment of a seasoned executive like Jeffrey A. Craig, with experience in various leadership roles, is a common practice for public companies to enhance their board's capabilities and governance.
Comparison to Industry Standards
- The appointment of a former CEO and CFO to a board is a common practice among large public companies like Baxter.
- Companies such as Medtronic and Johnson & Johnson also have board members with similar backgrounds in finance and operations.
- The compensation and equity awards for non-employee directors are consistent with industry standards for companies of Baxter's size and complexity.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Jeffrey A. Craig | September 8, 2024 | Appointment to the Board |
Stakeholder Impact
- Shareholders may view the appointment of an experienced director positively.
- Employees may see this as a sign of strong corporate governance.
- The appointment is unlikely to have a direct impact on customers or suppliers.
Next Steps
- Mr. Craig will begin his service on the Board and Audit Committee.
- He will receive equity awards for his service from September 8, 2024, to the 2025 annual meeting of stockholders.
Key Dates
| Date | Description |
|---|---|
| February 8, 2024 | Date of filing of the company's Annual Report on Form 10-K, which includes the Non-Employee Director Compensation Plan. |
| March 25, 2024 | Date of filing of the company's definitive proxy statement for its 2024 annual meeting of stockholders. |
| September 8, 2024 | Date of Jeffrey A. Craig's appointment to the Board of Directors. |
| September 9, 2024 | Date of the 8-K filing and press release announcing the appointment of Jeffrey A. Craig. |
Keywords
Board of Directors, Jeffrey A. Craig, Audit Committee, Corporate Governance, Executive Appointment, Meritor, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.